<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04936620</url>
  </required_header>
  <id_info>
    <org_study_id>2021.0056</org_study_id>
    <secondary_id>25573423</secondary_id>
    <nct_id>NCT04936620</nct_id>
  </id_info>
  <brief_title>Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling</brief_title>
  <acronym>DISCUS</acronym>
  <official_title>Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St George's, University of London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St George's University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Mary's University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bristol</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Cambridge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Buckinghamshire Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St George's, University of London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      QUESTION. Does duroplasty improve outcome after spinal cord injury?&#xD;
&#xD;
      WHAT DO WE STUDY? We will investigate whether performing a surgical procedure called&#xD;
      duroplasty improves outcomes after spinal cord injury.&#xD;
&#xD;
      WHY SPINAL CORD INJURY? Spinal cord injury is a devastating condition that causes permanent&#xD;
      disability such as paralysis, numbness and loss of bladder and bowel control. Currently,&#xD;
      there are no treatments shown to improve outcome after spinal cord injury.&#xD;
&#xD;
      WHAT IS DUROPLASTY? Duroplasty is an operation that involves opening the tough membrane&#xD;
      around the cord, called the dura, and stitching a patch of artificial dura to expand the&#xD;
      space around the swollen cord.&#xD;
&#xD;
      WHY IS DUROPLASTY BEING STUDIED? Based on our preliminary evidence, we think that the dura&#xD;
      causes cord pressure after injury. We have shown in a small study of patients that performing&#xD;
      this operation safely and effectively reduces pressure on the injured cord.&#xD;
&#xD;
      WHO IS ELIGIBLE? Adult patients with severe spinal cord injuries in the neck who will have&#xD;
      surgery within 72 hours.&#xD;
&#xD;
      WHAT TREATMENT? Those who agree to take part will be allocated by chance (like tossing a&#xD;
      coin) to standard treatment or standard treatment plus duroplasty. Some patients will also be&#xD;
      asked to take part in a smaller study that involves placing probes at the injury site.&#xD;
&#xD;
      WHERE? We will recruit patients from U.K. Major Trauma Centres. Most assessments will be done&#xD;
      in U.K. Spinal Injury Centres. Later on, we may recruit from overseas.&#xD;
&#xD;
      HOW LONG? We aim to recruit 222 - 260 patients over 4 years. Patients will be followed up for&#xD;
      a year.&#xD;
&#xD;
      WHAT DO WE ASSESS? Patients will be assessed (using questionnaires and by examination) how&#xD;
      well they can use their hands, walk, control their bladder and bowel and their quality of&#xD;
      life. Some of these assessments will be repeated at 3, 6 and 12 months after surgery.&#xD;
&#xD;
      WHAT IS THE OPTIONAL MECHANISTIC STUDY? DISCUS includes an optional study for at least 50&#xD;
      patients who will take part in the randomised controlled trial. The aim of the mechanistic&#xD;
      study is to determine how duroplasty improves outcome, i.e. whether duroplasty reduces cord&#xD;
      compression, improves blood flow to the injured cord perfusion, improves cord metabolism and&#xD;
      reduces cord inflammation.&#xD;
&#xD;
      WHAT IS THE OPTIONAL INFORMATION STUDY? For the first two years, a study called QuinteT&#xD;
      Recruitment Intervention (QRI) is designed to optimise patient recruitment and informed&#xD;
      consent in the trauma setting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RESEARCH QUESTION: After severe traumatic spinal cord injury (TSCI), does the addition of&#xD;
      dural decompression to bony decompression (includes laminectomy) improve muscle strength in&#xD;
      the limbs at 6 months, compared with bony decompression alone? BACKGROUND: TSCI is a&#xD;
      devastating condition that affects about 1,000 people in the UK annually. Most remain&#xD;
      disabled, tetraplegic or wheelchair bound and are dependent on carers with significant cost&#xD;
      to patients, carers and the NHS. Surgery aims to reduce spinal deformity, stabilise the spine&#xD;
      and achieve bony decompression of the cord. To date, no treatments have been shown to improve&#xD;
      outcome.&#xD;
&#xD;
      AIMS / OBJECTIVES: The primary aim is to determine if, in patients with acute, severe TSCI,&#xD;
      the addition of dural decompression to bony decompression improves muscle strength. We&#xD;
      hypothesise that, after TSCI, the cord swells and is compressed against the dura. Secondary&#xD;
      objectives are to assess patient impact i.e. functional outcomes, health related quality of&#xD;
      life (HRQoL), complication rates and mortality. Mechanistic sub-studies aim to determine if&#xD;
      the addition of duroplasty improves cord perfusion, reduces cord ischaemia and cord&#xD;
      inflammation.&#xD;
&#xD;
      METHODS: This is a prospective, phase III, multicentre randomised controlled trial (RCT). We&#xD;
      aim to recruit 222 adults with acute, severe cervical TSCI (American spinal injuries&#xD;
      association Impairment Scale (AIS) grade A, B or C) who will be randomised 1:1 to undergo&#xD;
      bony decompression alone versus bony decompression with duroplasty. Patients and assessors&#xD;
      will be blinded to study arm. The primary outcome is change in AIS motor score (AMS) at 6&#xD;
      months compared with admission (Delta-AMS); secondary outcomes will assess function (grasp,&#xD;
      walking, urinary + anal sphincters), HRQoL, complications, need for further surgery and&#xD;
      mortality, assessed at baseline, 3 months, 6 months and 12 months from randomisation. A&#xD;
      subgroup of 50 patients (25 per arm) will also have observational monitoring from the injury&#xD;
      site using a pressure probe (intraspinal pressure ISP, spinal cord perfusion pressure SCPP)&#xD;
      and microdialysis (MD) catheter (cord metabolism: tissue glucose, lactate, pyruvate,&#xD;
      lactate-to-pyruvate ratio (LPR), glutamate, glycerol); cord inflammation: tissue&#xD;
      chemokines/cytokines. Patients will be recruited from the 26 UK major trauma centres (MTCs).&#xD;
&#xD;
      TIMELINES FOR DELIVERY: The study duration is 72 months and includes 6 months set-up, 48&#xD;
      months recruitment, 12 months to complete follow-up and 6 months for data analysis and final&#xD;
      reporting of results. There will be a formal stop/go review at month 15 (after 9 months of&#xD;
      recruitment) to ensure a minimum of 4 sites have been opened and 8 patients randomised. If&#xD;
      these targets are met, the trial will recruit for a further 36 months. Data from the pilot&#xD;
      will be included in the final analysis.&#xD;
&#xD;
      ANTICIPATED IMPACT AND DISSEMINATION: It is anticipated that the addition of duroplasty to&#xD;
      standard of care will improve muscle strength in patients; this has obvious benefits for&#xD;
      patients and their carers as well as substantial gains for the NHS and society including&#xD;
      economic implications. If this RCT shows that the addition of duroplasty to standard&#xD;
      treatment is beneficial, it is anticipated that duroplasty will become standard NHS care in&#xD;
      all 26 UK MTCs. Participants will be informed of study findings via the Surgical Intervention&#xD;
      Trials Unit (SITU) website and the Spinal Injuries Association (SIA).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">September 2026</completion_date>
  <primary_completion_date type="Anticipated">January 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Phase III clinical trial: randomised, controlled, double blind, multi-centre, superiority&#xD;
+ Optional mechanistic study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants, some care providers (ie: physiotherapists) and outcome assessor will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in AIS motor score</measure>
    <time_frame>6 months versus baseline</time_frame>
    <description>Change in American Spinal Injury Association Impairment Scale total limb motor score at 6 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in AIS light touch score</measure>
    <time_frame>6 months versus baseline</time_frame>
    <description>Change in American Spinal Injury Association Impairment Scale total light touch sensory score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in AIS pin prick score</measure>
    <time_frame>6 months versus baseline</time_frame>
    <description>Change in American Spinal Injury Association Impairment Scale total pin prick sensory score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in AIS grade</measure>
    <time_frame>6 months versus baseline</time_frame>
    <description>Change in American Spinal Injury Association grade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CUU-Q</measure>
    <time_frame>6 moths</time_frame>
    <description>Capabilities of upper extremity-questionnaire (CUE-Q)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength</measure>
    <time_frame>6 months</time_frame>
    <description>Hand grip strength assessed with dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WISCI II</measure>
    <time_frame>6 months</time_frame>
    <description>Walking Index for Spinal Cord Injury version ii</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SCIM III</measure>
    <time_frame>6 months</time_frame>
    <description>Spinal Cord Independence Measure version III</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
    <description>Short Form survey 36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spinal re-operations</measure>
    <time_frame>12 months</time_frame>
    <description>Number of reoperations on spine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>12 months</time_frame>
    <description>Procedure Specific complications and adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>12 months</time_frame>
    <description>Mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>12 months</time_frame>
    <description>Length of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRI</measure>
    <time_frame>2 weeks, 6 months</time_frame>
    <description>Magnetic resonance imaging of cervical spine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Injury site physiology and metabolism (optional)</measure>
    <time_frame>Up to 5 days after surgery</time_frame>
    <description>Optional mechanistic study: Mean daily intraspinal pressure, spinal cord perfusion pressure, tissue glucose, lactate, pyruvate, glycerol, glutamate, cytokines measured from the injury site</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">222</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <arm_group>
    <arm_group_label>Duroplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Duroplasty (includes Surgery with Laminectomy)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No duroplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No duroplasty (but includes surgery with Laminectomy)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Duroplasty</intervention_name>
    <description>Expansion Duroplasty</description>
    <arm_group_label>Duroplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spinal surgery</intervention_name>
    <description>Spinal surgery including laminectomy</description>
    <arm_group_label>Duroplasty</arm_group_label>
    <arm_group_label>No duroplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age â‰¥16 years&#xD;
&#xD;
          2. Severe cervical (C2 - T1) traumatic spinal cord injury (AIS grade A-C)&#xD;
&#xD;
          3. Deemed to require and be suitable for surgery that includes laminectomy by local&#xD;
             surgeon&#xD;
&#xD;
          4. Surgery within 72 hours of traumatic spinal cord injury&#xD;
&#xD;
          5. Able to provide informed consent or consultee declaration or proxy consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Dural tear due to traumatic spinal cord injury&#xD;
&#xD;
          2. Life-limiting or rehabilitation-restricting co-morbidities&#xD;
&#xD;
          3. Thoracic or lumbar traumatic spinal cord injury&#xD;
&#xD;
          4. Other central nervous system disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marios C Papadopoulos</last_name>
    <role>Principal Investigator</role>
    <affiliation>St George's, University of London, U.K.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samira Saadoun</last_name>
    <role>Principal Investigator</role>
    <affiliation>St George's, University of London, U.K.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Parisa Sinai</last_name>
    <phone>079 17100953</phone>
    <email>discus@nds.ox.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rosie Jacobs</last_name>
    <email>rjacobs@sgul.ac.uk</email>
  </overall_contact_backup>
  <link>
    <url>https://fundingawards.nihr.ac.uk/award/NIHR130048</url>
    <description>DISCUS NIHR Research Award</description>
  </link>
  <link>
    <url>https://doi.org/10.1186/ISRCTN25573423</url>
    <description>DISCUS ISRCTN registry</description>
  </link>
  <reference>
    <citation>Werndle MC, Saadoun S, Phang I, Czosnyka M, Varsos GV, Czosnyka ZH, Smielewski P, Jamous A, Bell BA, Zoumprouli A, Papadopoulos MC. Monitoring of spinal cord perfusion pressure in acute spinal cord injury: initial findings of the injured spinal cord pressure evaluation study*. Crit Care Med. 2014 Mar;42(3):646-55. doi: 10.1097/CCM.0000000000000028.</citation>
    <PMID>24231762</PMID>
  </reference>
  <reference>
    <citation>Phang I, Werndle MC, Saadoun S, Varsos G, Czosnyka M, Zoumprouli A, Papadopoulos MC. Expansion duroplasty improves intraspinal pressure, spinal cord perfusion pressure, and vascular pressure reactivity index in patients with traumatic spinal cord injury: injured spinal cord pressure evaluation study. J Neurotrauma. 2015 Jun 15;32(12):865-74. doi: 10.1089/neu.2014.3668. Epub 2015 May 4.</citation>
    <PMID>25705999</PMID>
  </reference>
  <reference>
    <citation>Phang I, Zoumprouli A, Papadopoulos MC, Saadoun S. Microdialysis to Optimize Cord Perfusion and Drug Delivery in Spinal Cord Injury. Ann Neurol. 2016 Oct;80(4):522-31. doi: 10.1002/ana.24750. Epub 2016 Aug 19.</citation>
    <PMID>27463064</PMID>
  </reference>
  <reference>
    <citation>Saadoun S, Papadopoulos MC. Acute, Severe Traumatic Spinal Cord Injury: Monitoring from the Injury Site and Expansion Duraplasty. Neurosurg Clin N Am. 2021 Jul;32(3):365-376. doi: 10.1016/j.nec.2021.03.008. Epub 2021 May 7. Review.</citation>
    <PMID>34053724</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 21, 2021</study_first_submitted>
  <study_first_submitted_qc>June 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>June 21, 2021</last_update_submitted>
  <last_update_submitted_qc>June 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Decompression, surgical; Neurosurgery; Paralysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Appropriately anonymised datasets from our sponsored research will be made available for further analysis wherever possible under our Research Data Management policy:&#xD;
https://www.sgul.ac.uk/about/governance/policies/research-data-management</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Publications on this study will be available form PubMed, Study website and other publicly accessible resources.</ipd_time_frame>
    <ipd_access_criteria>Specific requests for data sharing should be directed to sponsor St George's University London.</ipd_access_criteria>
    <ipd_url>https://www.sgul.ac.uk/about/governance/policies/research-data-management</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

